FDA clears STARMED's thyroid nodule RFA device

STARMED received U.S. FDA clearance for a radiofrequency ablation (RFA) device intended to treat thyroid nodules, providing a minimally invasive option that may reduce the need for surgery.

• The clearance was for the STARMED thyroid nodule RFA device (exact model name not provided in the source).
• This expands available minimally invasive treatment options for patients with benign or symptomatic thyroid nodules.
• The announcement is based on a company press release; independent clinical data were not disclosed in the source.

RadPigeon summaries are original and for information only. They are not clinical advice.